Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies

Bibliographic Details
Main Authors: Jeffrey Schlom, Claudia Palena, Sofia R Gameiro, Lucas A Horn, Kristin C Hicks, Christine M Minnar, Paul L Chariou
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/6/e004561.full
_version_ 1811238393459245056
author Jeffrey Schlom
Claudia Palena
Sofia R Gameiro
Lucas A Horn
Kristin C Hicks
Christine M Minnar
Paul L Chariou
author_facet Jeffrey Schlom
Claudia Palena
Sofia R Gameiro
Lucas A Horn
Kristin C Hicks
Christine M Minnar
Paul L Chariou
author_sort Jeffrey Schlom
collection DOAJ
first_indexed 2024-04-12T12:40:54Z
format Article
id doaj.art-c40ceb0f60fb49e39cb33a9a377eeb7f
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-04-12T12:40:54Z
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-c40ceb0f60fb49e39cb33a9a377eeb7f2022-12-22T03:32:46ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262022-06-0110610.1136/jitc-2022-004561Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficienciesJeffrey Schlom0Claudia Palena1Sofia R Gameiro2Lucas A Horn3Kristin C Hicks4Christine M Minnar5Paul L Chariou6Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USALaboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USALaboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USALaboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USALaboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USACenter for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USACenter for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USAhttps://jitc.bmj.com/content/10/6/e004561.full
spellingShingle Jeffrey Schlom
Claudia Palena
Sofia R Gameiro
Lucas A Horn
Kristin C Hicks
Christine M Minnar
Paul L Chariou
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies
Journal for ImmunoTherapy of Cancer
title Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies
title_full Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies
title_fullStr Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies
title_full_unstemmed Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies
title_short Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies
title_sort tumor targeted interleukin 12 synergizes with entinostat to overcome pd 1 pd l1 blockade resistant tumors harboring mhc i and apm deficiencies
url https://jitc.bmj.com/content/10/6/e004561.full
work_keys_str_mv AT jeffreyschlom tumortargetedinterleukin12synergizeswithentinostattoovercomepd1pdl1blockaderesistanttumorsharboringmhciandapmdeficiencies
AT claudiapalena tumortargetedinterleukin12synergizeswithentinostattoovercomepd1pdl1blockaderesistanttumorsharboringmhciandapmdeficiencies
AT sofiargameiro tumortargetedinterleukin12synergizeswithentinostattoovercomepd1pdl1blockaderesistanttumorsharboringmhciandapmdeficiencies
AT lucasahorn tumortargetedinterleukin12synergizeswithentinostattoovercomepd1pdl1blockaderesistanttumorsharboringmhciandapmdeficiencies
AT kristinchicks tumortargetedinterleukin12synergizeswithentinostattoovercomepd1pdl1blockaderesistanttumorsharboringmhciandapmdeficiencies
AT christinemminnar tumortargetedinterleukin12synergizeswithentinostattoovercomepd1pdl1blockaderesistanttumorsharboringmhciandapmdeficiencies
AT paullchariou tumortargetedinterleukin12synergizeswithentinostattoovercomepd1pdl1blockaderesistanttumorsharboringmhciandapmdeficiencies